Clinical Trials Logo

Airway Obstruction clinical trials

View clinical trials related to Airway Obstruction.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02317042 Terminated - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

Juno Perth Clinical Trial

Start date: May 29, 2015
Phase: N/A
Study type: Interventional

This study is to evaluate the efficacy of a new therapy (Automatic Expiratory Positive Airway Pressure with intelligent Volume Assured Pressure Support (AutoEPAP iVAPS)) designed to treat respiratory insufficiency, respiratory failure and/or nocturnal hypoventilation with upper airway obstruction. The study will be performed in two phases: In a sleep unit and in the home environment. The new therapy will be compared against two existing ventilator therapies: "Spontaneous Timed (ST) mode" and "Intelligent Volume Assured Pressure Support (iVAPS)".

NCT ID: NCT01799395 Terminated - Lung Cancer Clinical Trials

Prevalence and Incidence of Central Airway Obstruction in Advanced Lung Cancer

Start date: February 2013
Phase: N/A
Study type: Observational

Lung cancer may cause central airway obstruction through several different mechanisms (invasion by the primary tumor, invasion by metastatic lymph nodes, airway metastasis). The aim of the present study is to determine the prevalence at the time of diagnosis, the incidence at 1 year from the diagnosis, and the predictors of central airway obstruction associated with advanced lung cancer.

NCT ID: NCT01064050 Terminated - Clinical trials for Carcinoma, Non-Small-Cell Lung

Role of a Silicone Prosthesis to Prevent Airway Obstruction Recurrence in Lung Cancers

SPOC
Start date: November 2008
Phase: Phase 4
Study type: Interventional

A tumoral obstruction of the main stem bronchus is frequently observed in the follow-up of lung cancers with a high impact on survival and quality of life of these patients. The endoluminal resection of these tumors through interventional bronchoscopy can remove the tumor but fails to prevent the recurrence. A stent insertion could achieve this goal but this option was never proved in a prospective protocol. The aim of this study is to analyze the impact of stent insertion on the survival without symptoms of bronchial obstruction in patients treated for their cancer with and without a first line treatment (chemo-radiotherapy or chemotherapy). The patients will be included after resection of the endoluminal symptomatic tumoral obstruction. We will test the effect of the silicone stent insertion ( from NovatechR ) by comparing a stent arm (170 patients with stent insertion) with a control arm (170 patients without stent). The inclusion period will last 3 years with one year of follow-up for each patient. The one-year survival without symptomatic recurrence (proved on bronchoscopy with more than 50% of obstruction in the treated zone) will be the main endpoint. All patients without symptomatic recurrence at one year will be controlled endoscopically. Survival and stent tolerance will be studied as secondary endpoints. All endoscopic events will be depicted on photographs or videos. Each endoscopical situation (before and after resection, recurrence or side effects of stents) will be analyzed and registered by an independent committee of 3 international experts.

NCT ID: NCT00950443 Terminated - Airway Obstruction Clinical Trials

Acoustic Reflection Method and Work of Breathing

MAVAS
Start date: December 2009
Phase: N/A
Study type: Interventional

Upper airway obstruction (UAO) is very common in children. Presently, the importance of the UAO is evaluated by the physician during an endoscopic evaluation under general anaesthesia. The aim of the study is to evaluate two new techniques to quantify the importance of the UAO in children; the acoustic reflection method and the measurement of the work of breathing. 80 children will be included in this monocentric, prospective, open labelled study.